What are the risks of not undergoing screening colonoscopy (Colonoscopy) for colorectal cancer?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Risks of Not Undergoing Screening Colonoscopy

Not undergoing screening colonoscopy significantly increases your risk of dying from colorectal cancer, with studies showing approximately double the mortality risk compared to those who complete screening.

Mortality Risk

The most critical consequence of forgoing colonoscopy screening is increased colorectal cancer mortality:

  • For individuals with a 4% baseline risk of colorectal cancer over 15 years, no screening results in 13 deaths per 1,000 people, compared to only 5 deaths per 1,000 with colonoscopy screening 1
  • Non-compliance with colonoscopy after a positive fecal immunochemical test (FIT) results in a 103% increased risk of death from colorectal cancer (adjusted HR 2.03; 95% CI 1.68-2.44), with 10-year cumulative mortality of 16.0 per 1,000 in non-compliers versus 6.8 per 1,000 in compliers 2
  • This mortality difference translates to more than doubling your risk of dying from colorectal cancer when you skip recommended colonoscopy 2

Cancer Incidence Risk

Beyond mortality, not screening increases your likelihood of developing colorectal cancer:

  • The 10-year risk of colorectal cancer is 1.20% without screening versus 0.98% with colonoscopy invitation (18% risk reduction with screening) 3
  • Among FIT-positive individuals who don't undergo colonoscopy, the 10-year cumulative incidence of colorectal cancer is 54.3 per 1,000 compared to 44.7 per 1,000 in those who complete colonoscopy 2
  • The number needed to invite to screening to prevent one case of colorectal cancer is 455 3

Stage at Diagnosis

Without screening, cancers are detected at more advanced stages when treatment is less effective:

  • Delays in colonoscopy beyond 6 months after a positive FIT result in significantly higher risks: adjusted OR 1.31 for any colorectal cancer and 2.09 for advanced stage disease 1
  • Delays beyond 12 months further increase risk: adjusted OR 2.17 for any colorectal cancer and 2.84 for advanced stage disease 1
  • Patients with localized colorectal cancer have 90% 5-year survival, compared to only 14% for distant disease 1

Long-Term Protective Effect Lost

Colonoscopy provides durable protection that extends for years:

  • A negative colonoscopy provides protection for at least 10 years, with very low risk of advanced neoplasia within 5 years (1.3%-2.4%) 1
  • Among adults ages 76-85 with a negative colonoscopy 10 years earlier, cumulative colorectal cancer incidence remains low at 1.29% at 8 years 4
  • Case-control studies demonstrate risk reduction lasting 10 years or more after colonoscopy 1

Missed Opportunity for Prevention

Colonoscopy uniquely allows removal of precancerous lesions:

  • Colonoscopy can prevent cancer by detecting and removing adenomatous polyps before they progress to malignancy 1, 5
  • This preventive benefit is lost with non-invasive screening methods that only detect existing cancer 5
  • The high sensitivity of colonoscopy for precancerous lesions of all sizes enables 10-year screening intervals (potentially extending to 15 years) 5

Common Pitfalls

Critical consideration: The evidence shows that adherence to any screening method is more important than which specific test is chosen 1. However, when colonoscopy is specifically indicated (such as after positive FIT), failure to complete it carries substantial mortality risk 2.

System barriers frequently contribute to non-compliance, including failure to arrange colonoscopy, failure to inform patients of positive results, and inadequate patient contact 1. These should be addressed proactively.

For high-risk individuals (family history, inflammatory bowel disease, genetic syndromes), colonoscopy is the preferred screening method, and alternatives may be inadequate 1, 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Risk of Colorectal Cancer and Colorectal Cancer Mortality Beginning Ten Years after a Negative Colonoscopy, among Screen-Eligible Adults 76 to 85 Years Old.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.